Some metabolic diseases that are simultaneously associated with aging can be easily identified and managed by assessing specific biomarkers (e.g., pro-inflammatory cytokines—tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)). This evidence concerns the gene TNF and Other metabolic disease.